Another Bay Area biotech files plans to go public
January 08, 2019 at 09:34 AM EST
The company is focused on helping the immune system hunt down invaders that may trigger Alzheimer's and other neurological diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|